Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Accumulated Expenses (2018 - 2023)

Dna X's Other Accumulated Expenses history spans 6 years, with the latest figure at $260000.0 for Q3 2023.

  • Quarterly results put Other Accumulated Expenses at $260000.0 for Q3 2023, up 182.61% from a year ago — trailing twelve months through Sep 2023 was $260000.0 (up 182.61% YoY), and the annual figure for FY2022 was $171000.0, down 49.85%.
  • Other Accumulated Expenses for Q3 2023 was $260000.0 at Dna X, up from $166000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $851000.0 in Q4 2019 to a low of $16000.0 in Q1 2023.
  • The 5-year median for Other Accumulated Expenses is $228000.0 (2022), against an average of $293000.0.
  • Peak annual rise in Other Accumulated Expenses hit 182.61% in 2023, while the deepest fall reached 94.63% in 2023.
  • Year by year, Other Accumulated Expenses stood at $851000.0 in 2019, then plummeted by 36.66% to $539000.0 in 2020, then crashed by 36.73% to $341000.0 in 2021, then crashed by 49.85% to $171000.0 in 2022, then surged by 52.05% to $260000.0 in 2023.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $260000.0, $166000.0, and $16000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.